12 January 2022 - appointment
Shares in the AIM-listed infection prevention technology group may be worth a look following the recent decline in the share price. This hit 7.5p last year and 9.75p in the summer of 2020 when the group's infection control products such as sanitisers were in high demand. Although this level of demand has declined the company will still benefit from the fact that consumers are more conscious of the need to sanitise and prevent the spread of infection. Today's announcement that the company has appointed a new Chief Growth Officer with considerable . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
